tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SLXN Stock Latest News

Buy Rating Affirmed for Silexion Therapeutics: Promising Preclinical Data and Strategic Trial Plans Boost Investment Appeal
RatingsBuy Rating Affirmed for Silexion Therapeutics: Promising Preclinical Data and Strategic Trial Plans Boost Investment Appeal
10d ago
SLXN
Silexion Therapeutics Unveils Promising SIL204 Data
PremiumCompany Announcements
Silexion Therapeutics Unveils Promising SIL204 Data
11d ago
8K
SLXN
Silexion Therapeutics announces new data in SIL204
PremiumThe Fly
Silexion Therapeutics announces new data in SIL204
11d ago
SLXN
Silexion Therapeutics files $100M mixed securities shelf
PremiumThe Fly
Silexion Therapeutics files $100M mixed securities shelf
15d ago
SLXN
Silexion Therapeutics Enters Market Offering Agreement
PremiumCompany Announcements
Silexion Therapeutics Enters Market Offering Agreement
15d ago
8K
SLXN
Silexion Therapeutics regains compliance with Nasdaq listing requirements
PremiumThe FlySilexion Therapeutics regains compliance with Nasdaq listing requirements
16d ago
SLXN
Silexion Restores Nasdaq Compliance After Strategic Moves
Premium
Company Announcements
Silexion Restores Nasdaq Compliance After Strategic Moves
16d ago
8K
SLXN
Silexion Therapeutics Converts Debt to Equity for Nasdaq Compliance
Premium
Company Announcements
Silexion Therapeutics Converts Debt to Equity for Nasdaq Compliance
26d ago
8K
SLXN
Silexion Therapeutics Announces $6M Public Offering
PremiumCompany Announcements
Silexion Therapeutics Announces $6M Public Offering
29d ago
8K
SLXN
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
30d ago
KR
AMD
Silexion Therapeutics prices 1.5M shares at $4.00 in public offering
PremiumThe Fly
Silexion Therapeutics prices 1.5M shares at $4.00 in public offering
30d ago
SLXN
Why Is Silexion Therapeutics Stock (SLXN) Up 190% Today?
PremiumMarket News
Why Is Silexion Therapeutics Stock (SLXN) Up 190% Today?
30d ago
SLXN
Silexion Therapeutics Reveals Positive Preclinical Data for SIL204
PremiumCompany AnnouncementsSilexion Therapeutics Reveals Positive Preclinical Data for SIL204
30d ago
8K
SLXN
Silexion Therapeutics announces preclinical data on SIL204
Premium
The Fly
Silexion Therapeutics announces preclinical data on SIL204
30d ago
SLXN
Silexion Therapeutics Partners with AMS for Clinical Trials
Premium
Company Announcements
Silexion Therapeutics Partners with AMS for Clinical Trials
1M ago
8K
SLXN
Silexion Therapeutics selects AMS as CRO for SIL204 Phase 2/3 trials
PremiumThe Fly
Silexion Therapeutics selects AMS as CRO for SIL204 Phase 2/3 trials
1M ago
SLXN
Silexion Therapeutics Unveils New Oncogene Therapy Updates
PremiumCompany Announcements
Silexion Therapeutics Unveils New Oncogene Therapy Updates
1M ago
8K
SLXN
Silexion Therapeutics Executes Reverse Stock Split
PremiumCompany Announcements
Silexion Therapeutics Executes Reverse Stock Split
2M ago
8K
SLXN
Silexion Therapeutics Increases Authorized Share Capital
PremiumCompany Announcements
Silexion Therapeutics Increases Authorized Share Capital
2M ago
8K
SLXN
Silexion Therapeutics reports Q2 EPS ($4.32) vs. ($197.80) last year
PremiumThe FlySilexion Therapeutics reports Q2 EPS ($4.32) vs. ($197.80) last year
2M ago
SLXN
Buy Rating for Silexion Therapeutics Driven by Promising Preclinical Data and Financial Strength
Premium
Ratings
Buy Rating for Silexion Therapeutics Driven by Promising Preclinical Data and Financial Strength
2M ago
SLXN
Silexion Therapeutics Enters Inducement Offer Agreement
Premium
Company Announcements
Silexion Therapeutics Enters Inducement Offer Agreement
2M ago
8K
SLXN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >